Immune regulation in chronic hepatitis C virus infection

被引:18
|
作者
Hartling, Hans Jakob [1 ]
Ballegaard, Vibe Cecilie [1 ]
Nielsen, Nick Schou [1 ]
Gaardbo, Julie Christine [1 ]
Nielsen, Susanne Dam [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Infect Dis, Viroimmunol Res Unit, DK-1168 Copenhagen, Denmark
关键词
Chronic hepatitis C; HCV; adaptive immunology; MiRNA; regulatory T cells; IL-10; TGF-b; NATURAL-KILLER-CELLS; CD8(+) T-CELLS; INTERFERON-FREE THERAPY; NK CELLS; HEPATOCELLULAR-CARCINOMA; STELLATE CELLS; HCV INFECTION; FUNCTIONAL RESTORATION; MICRORNA EXPRESSION; ALPHA-INTERFERON;
D O I
10.3109/00365521.2016.1170875
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The immunological result of infection with Hepatitis C virus (HCV) depends on the delicate balance between a vigorous immune response that may clear the infection, but with a risk of unspecific inflammation and, or a less inflammatory response that leads to chronic infection. In general, exhaustion and impairment of cytotoxic function of HCV-specific T cells and NK cells are found in patients with chronic HCV infection. In contrast, an increase in immune regulatory functions is found primarily in form of increased IL-10 production possibly due to increased level and function of anti-inflammatory Tregs. Thus, the major immune players during chronic HCV infection are characterized by a decrease of cytotoxic function and increase of inhibitory functions. This may be an approach to diminish intrahepatic and systemic inflammation. Finally, there has been increasing awareness of regulatory functions of epigenetic changes in chronic HCV infection. A vast amount of studies have revealed the complexity of immune regulation in chronic HCV infection, but the interplay between immune regulation in virus and host remains incompletely understood. This review provides an overview of regulatory functions of HCV-specific T cells, NK cells, Tregs, IL-10, and TGF-, as well as epigenetic changes in the setting of chronic HCV infection.
引用
收藏
页码:1387 / 1397
页数:11
相关论文
共 50 条
  • [21] Immune therapy of hepatitis B virus chronic infection
    Pol, S
    Michel, ML
    Bréchot, C
    HEPATOLOGY, 2000, 31 (02) : 548 - 549
  • [22] Treatment of chronic hepatitis C virus infection
    Malnick, SDH
    Beergabel, M
    Lurie, Y
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (10) : 1156 - 1164
  • [23] Chronic Hepatitis C Virus Infection in Children
    Mohan, Neelam
    Gonzalez-Peralta, Regino P.
    Fujisawa, Tomoo
    Chang, Wei-Hwei
    Heller, Solange
    Jara, Paloma
    Kelly, Deirdre
    Mieli-Vergani, Giorgina
    Shah, Uzma
    Murray, Karen F.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 (02): : 123 - 131
  • [24] Telaprevir for Chronic Hepatitis C Virus Infection
    Jesudian, Arun B.
    Jacobson, Ira M.
    CLINICS IN LIVER DISEASE, 2013, 17 (01) : 47 - +
  • [25] Chronic hepatitis C virus infection and autoimmunity
    Mora, G.
    Spiraquis, A.
    Alejandro, C.
    Venarotti, H.
    LIVER INTERNATIONAL, 2006, 26 : 85 - 85
  • [26] Arthritis and chronic hepatitis C virus infection
    Puerto, J.
    Escobar, M. A.
    Garcia-Egido, A. A.
    Fernandez, F. J.
    Gomez-Soto, F. M.
    Bernal, J. A.
    Romero, S. P.
    Gomez, F.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S336 - S337
  • [27] Cryoglobulins in chronic hepatitis C virus infection
    Trendelenburg, M
    Schifferli, JA
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (02): : 153 - 155
  • [28] Pathogenesis of chronic hepatitis C virus infection
    Nelson, DR
    Lau, JYN
    ANTIVIRAL THERAPY, 1998, 3 : 25 - 35
  • [29] Immunopathogenesis of chronic hepatitis C virus infection
    Li, DY
    Schwarz, KB
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 35 (03): : 260 - 267
  • [30] Cholesterol and chronic hepatitis C virus infection
    Honda, Akira
    Matsuzaki, Yasushi
    HEPATOLOGY RESEARCH, 2011, 41 (08) : 697 - 710